Categories AlphaGraphs, Earnings, Health Care
Abbott Laboratories ease past street targets: Infographic
Abbott Laboratories (NYSE: ABT) reported second-quarter 2021 financial results before the regular market hours on Thursday. The pharmaceutical giant reported Q2 sales of $ 10.2 billion, up 40% year-over-year and higher than the Wall Street projection. Net income of $1.17 per share was also above the target that analysts had anticipated.
ABT shares rose 0.4% immediately following the announcement. The stock has gained 9% since the beginning of this year.
Prior performance
Most Popular
Snowflake (SNOW) appears to be on solid footing despite cloud slowdown
The cloud computing market witnessed accelerated growth in the last couple of years, as enterprises across the world shifted their digital assets to cloud for ensuring safety and enhancing data
Dollar Tree (DLTR) vs. Dollar General (DG): How did the third quarter turn out for these discount retailers?
In times of high inflation and economic uncertainty, consumers tend to turn to discount retailers in search of more value. The two leading discount retailers Dollar Tree Inc. (NASDAQ: DLTR)
Kroger (KR) looks set to start 2023 with new vigor. Is the stock a buy?
The retail environment has witnessed many changes in customers’ shopping behavior lately, especially after the COVID outbreak. With inflation putting pressure on personal finances, there appears to be a new
